A vast majority of cancers show no symptoms until late stages, when treatment is complex, painful, traumatic, with poor clinical outcomes and financially toxic.
A vast majority of cancers show no symptoms until late stages, when treatment is complex, painful, traumatic, with poor clinical outcomes and financially toxic.
> 0.9 mil new cancer patients each year do not have access to any cancer screening solution
*Source: Globocan 2020
India’s cancer screening gap needs closure as it is the main cause for late stage detection of cancer where treatment becomes difficult or impossible
India’s cancer reality
> 0.9 mil new cancer patients each year do not have access to any cancer screening solution
*Source: Globocan 2020
India’s cancer screening gap needs closure as it is the main cause for late stage detection of cancer where treatment becomes difficult or impossible
The Solution
PanTum® Detect - A multi-tumor screening blood test for asymptomatic healthy individuals
“Cancer-Scan" program combines blood testing with advanced imaging techniques into an integrated multi tumor screening concept for detection of cancer and pre-cancerous lesions in early and symptomless stages for healthy individuals.
The best remedy for cancer is to never let it advance in the first place
Multi Tumor Screening test for Asymptomatic Healthy Population
Don't wait for onset of symptom's
KNOW IT NOW
Innovative & Unique
The EDIM technology is backed by science and more than 20 years of research
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes/Macrophages) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.
Leveraging the immune system to deliver high accuracy of PanTum® Detect test
The human immune system is first to recognize the progression of disease, even before the onset of symptoms. EDIM® (Epitope Detection in Monocytes/Macrophages) technology makes the information contained in the human immune system visible for detection of cancer. Higher than normal levels of Apo10 (DNaseX) & TKTL1 detected in immune cells (macrophages) of screened individuals gives an indication of potential cancer and pre-cancer lesions in early and symptomless stages for healthy individuals.